Association of hypertension drug target genes with blood pressure and hypertension in 86,588 individuals
about
Renal dopaminergic system: Pathophysiological implications and clinical perspectivesA modern understanding of the traditional and nontraditional biological functions of angiotensin-converting enzymeBlood pressure loci identified with a gene-centric arrayMechanisms of Vascular Smooth Muscle Contraction and the Basis for Pharmacologic Treatment of Smooth Muscle DisordersVariant Near FGF5 Has Stronger Effects on Blood Pressure in Chinese With a Higher Body Mass Index.Drug-Gene Interactions of Antihypertensive Medications and Risk of Incident Cardiovascular Disease: A Pharmacogenomics Study from the CHARGE ConsortiumA novel role for c-Myc in G protein-coupled receptor kinase 4 (GRK4) transcriptional regulation in human kidney proximal tubule cells.Diagnostic tools for hypertension and salt sensitivity testing.The Genetic Challenges and Opportunities in Advanced Heart FailurePopulation differences in associations of serotonin transporter promoter polymorphism (5HTTLPR) di- and triallelic genotypes with blood pressure and hypertension prevalence.GWAS and drug targets.Genetic and epigenetic catalysts in early-life programming of adult cardiometabolic disorders.Association between polymorphisms in the renin-angiotensin-aldosterone system genes and essential hypertension in the Han Chinese population.The genetics of common variation affecting platelet development, function and pharmaceutical targeting.Progress and future aspects in genetics of human hypertensionProtein interaction-based genome-wide analysis of incident coronary heart disease.Direct Estimates of the Genomic Contributions to Blood Pressure Heritability within a Population-Based Cohort (ARIC).Identification of a novel FGFRL1 MicroRNA target site polymorphism for bone mineral density in meta-analyses of genome-wide association studies.Genetic modifiers of hypertension in soluble guanylate cyclase α1-deficient miceGenome-wide association studies and contribution to cardiovascular physiologyAutonomic and hemodynamic origins of pre-hypertension: central role of heredity.Top Three Pharmacogenomics and Personalized Medicine Applications at the Nexus of Renal Pathophysiology and Cardiovascular Medicine.Multilocus family-based association analysis of seven candidate polymorphisms with essential hypertension in an african-derived semi-isolated brazilian population.Genes and Cardiovascular Disease: Where do we go from here?Frequencies of the Arg16Gly, Gln27Glu and Thr164Ile Adrenoceptor β2 Polymorphisms among Omanis.The State of Cardiovascular Genomics: Abundant Data, Limited Information.Blood pressure tracking over the adult life course: patterns and correlates in the Framingham heart studyHypertension susceptibility loci and blood pressure response to antihypertensives: results from the pharmacogenomic evaluation of antihypertensive responses study.Pathophysiology of hypertension in the absence of nitric oxide/cyclic GMP signaling.Hypertension pharmacogenomics: in search of personalized treatment approachesNew loci associated with birth weight identify genetic links between intrauterine growth and adult height and metabolismGenes for blood pressure: an opportunity to understand hypertensionA blood pressure genetic risk score is a significant predictor of incident cardiovascular events in 32,669 individualsLoci influencing blood pressure identified using a cardiovascular gene-centric array.Advancing management of hypertension through pharmacogenomicsGenetics, ancestry, and hypertension: implications for targeted antihypertensive therapiesCalcium Signaling Pathway Genes RUNX2 and CACNA1C Are Associated With Calcific Aortic Valve DiseaseDifferential influence of distinct components of increased blood pressure on cardiovascular outcomes: from the atherosclerosis risk in communities study.Renin-angiotensin-aldosterone system gene polymorphisms in gestational hypertension and preeclampsia: A case-control gene-association study.The association of alcohol intake with γ-glutamyl transferase (GGT) levels: evidence for correlated genetic effects
P2860
Q22241156-3B750CF0-C748-461C-BA00-FE82F3EEC004Q24306614-10A6B34F-D131-4A02-970C-B02E88F550DFQ24630508-F9674F4A-B318-47BB-9E9E-32D7FD3DC091Q26753129-239F2AC5-36A2-4A51-80E2-0EDB953A2ECEQ27304646-2FB01DB4-C645-4C6A-9A07-C5F22B3EEB3AQ28550578-C03217DD-9558-4EBD-8713-9D49C6CCDD6FQ30413354-9392DC49-FF25-436A-92C3-774863C79380Q30417367-0CA22DD3-38C2-401D-9CB0-22AB24DACE2BQ33653498-726A0DC2-CB4F-4AAF-9031-8E9DDF6D815AQ33806578-0A0F7E97-1790-4D72-81B8-0DAF90923984Q33851578-9FC089E0-7A92-412B-8452-D3BB086F91C6Q34637445-1CD7A45B-943D-4EB7-A872-5D36432599E8Q34981601-E43029E5-BA3F-4E5C-9416-9332DA5BCA1EQ35149898-7C8BE9F2-B0F0-450B-B2D4-3DE720313C6BQ35202339-3A392EA7-357D-4479-A1A5-5A47D6D499D0Q35400218-535C5209-DF3B-42BB-8C3C-F6E918855BD8Q35688249-B622E881-7F6A-4A04-8070-772EDCBDA6BAQ35882550-F614D6C8-8030-40B1-B725-D79F1799342DQ36005369-74F0ECE5-0B02-439A-84A6-9D2B55AADE5BQ36017794-8E73AF15-A2FD-4B92-B078-C7D0DA82E6E5Q36030841-7F427456-2CA3-4F53-B233-A8104331135FQ36285918-2B5B12B3-C61B-4799-9028-5544F716F25BQ36296452-A666BA99-58FB-4687-9E73-358F6700F66EQ36331319-D634D524-07F9-4C3B-A69C-564116BC1D06Q36331342-B6AD5269-9FDD-4A74-9660-44D09BF8CC5BQ36344018-0F658F29-3E0D-48AE-8A72-9655647A0C6CQ36403695-12ACBA60-5601-4EBD-A159-3D5196D22359Q36485487-C5BAD771-17A9-496F-94E7-B0FA45C2C0C9Q36532454-43EA45CA-D527-43D3-9E71-A8F5BDFD3714Q36652960-FC02FACB-74FC-422A-845A-1433CE4C107AQ36708957-A849E583-439F-450A-93F2-C183711CF6B7Q36730138-C81139A6-1A49-4ECC-A6D2-C836E5BE50E3Q36827527-060DD590-25C6-4D4B-8256-5A7AE80D9594Q36853815-F4643E83-7412-496D-9C34-B27ADF6355A8Q36939501-00A814A0-93AA-4D4D-83A2-CE7F55798A63Q36950310-F2CFD0B4-33EF-4ABC-B449-42B63EBEC764Q37070091-712055AD-99B7-4463-A593-BA1B41EFD8F9Q37309088-80E3EE10-1BA1-4E0D-8DE8-6C387808F1ADQ37464826-6B558790-D885-4804-BC8C-56C931C286DEQ37540492-1593931C-11F9-451A-9430-659544FF78A3
P2860
Association of hypertension drug target genes with blood pressure and hypertension in 86,588 individuals
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Association of hypertension dr ...... rtension in 86,588 individuals
@ast
Association of hypertension dr ...... rtension in 86,588 individuals
@en
Association of hypertension dr ...... rtension in 86,588 individuals
@nl
type
label
Association of hypertension dr ...... rtension in 86,588 individuals
@ast
Association of hypertension dr ...... rtension in 86,588 individuals
@en
Association of hypertension dr ...... rtension in 86,588 individuals
@nl
prefLabel
Association of hypertension dr ...... rtension in 86,588 individuals
@ast
Association of hypertension dr ...... rtension in 86,588 individuals
@en
Association of hypertension dr ...... rtension in 86,588 individuals
@nl
P2093
P2860
P50
P1433
P1476
Association of hypertension dr ...... rtension in 86,588 individuals
@en
P2093
Andrew D Johnson
Aravinda Chakravarti
Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium
Daniel I Chasman
Daniel Levy
Georg B Ehret
Germaine C Verwoert
Global BPgen Consortium
Kenneth Rice
Lynda Rose
P2860
P304
P356
10.1161/HYPERTENSIONAHA.110.158667
P407
P50
P577
2011-03-28T00:00:00Z